Sucampo Pharmaceuticals is a global pharmaceutical company engaged in the development and commercialization of medicines based on prostones, a class of compounds occurring naturally in the body. The company is focused on developing prostone-based compounds for the treatment of gastrointestinal, … Continue reading →

Bio-Path Holdings is a biotech company focused on developing therapeutic products utilizing its proprietary liposomal delivery technology, which was designed to systemically distribute nucleic acid drugs throughout the human body via intravenous infusion. BPTH is primarily focused on cancer; its … Continue reading →

ReNeuron Group is engaged in the research, development and commercial exploitation of stem cell technologies for therapeutic and non-therapeutic applications worldwide. Its lead therapeutic candidate is ReN001 stem cell therapy, which is in clinical development stage for the treatment of … Continue reading →

Inovio Pharmaceuticals is engaged in the development of synthetic vaccines, with a focus on cancers and infectious diseases. The company’s SynCon technology enables the design of universal vaccines capable of providing cross-protection against pathogens, such as influenza and human immunodeficiency … Continue reading →

Advanced Cell Technology is a biotech company that applies stem cell-based technologies (both adult and human embryonic) and other proprietary methods in the field of regenerative medicine. ACTC is also developing therapeutic platforms using corneal endothelial cells for use in … Continue reading →

Avita Medical develops and distributes regenerative and tissue-engineered products for the treatment of a broad range of wounds, scars and skin defects. The company’s lead product, ReCell® Spray-On Skin™, is CE-marked for Europe, TGA-registered in Australia, and SFDA-cleared in China. … Continue reading →

Amorfix Life Sciences is a theranostics company developing therapeutic products and diagnostic devices targeting misfolded protein diseases including ALS, cancer and Alzheimer’s Disease. The company offers two types of products: therapeutics, designed to target and neutralize only the misfolded conformation … Continue reading →

RXi Pharmaceuticals is a biotech company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform. RXi’s first RNAi product candidate, RXI-109, entered into RXi’s first human clinical trial in 2012. The candidate is initially … Continue reading →

ERBA Diagnostics is an emerging company in the global healthcare industry, operating in the core business segment of In Vitro Diagnostics (IVD). ERB’s product range includes a wide range of Clinical Chemistry Analyzers (Photometers & Fully Automated), Haematology analyzers, Urine … Continue reading →

Viropro, through its subsidiaries, engages in the contract research, development, and manufacturing of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial production of biogeneric therapeutic proteins … Continue reading →